
David W. Berke-schlessel
Examiner (ID: 6754, Phone: (571)270-3643 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651, 1799 |
| Total Applications | 867 |
| Issued Applications | 517 |
| Pending Applications | 104 |
| Abandoned Applications | 260 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19658835
[patent_doc_number] => 20240425900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => METHODS FOR DETERMINING AND/OR MONITORING THE HEALTH STATUS OF FISH
[patent_app_type] => utility
[patent_app_number] => 18/687075
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18687075
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/687075 | METHODS FOR DETERMINING AND/OR MONITORING THE HEALTH STATUS OF FISH | Aug 29, 2022 | Pending |
Array
(
[id] => 18391665
[patent_doc_number] => 20230159883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => METHODS AND COMPOSITIONS FOR PRESERVING BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/822860
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822860
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822860 | Methods and compositions for preserving bacteria | Aug 28, 2022 | Issued |
Array
(
[id] => 19815110
[patent_doc_number] => 20250073317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-06
[patent_title] => CHOLINE ACETYLTRANSFERASE AS A THERAPY FOR ENDOTOXEMIA, SEPSIS, COLITIS AND INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/293972
[patent_app_country] => US
[patent_app_date] => 2022-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18293972
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/293972 | CHOLINE ACETYLTRANSFERASE AS A THERAPY FOR ENDOTOXEMIA, SEPSIS, COLITIS AND INFLAMMATORY DISEASES | Aug 24, 2022 | Pending |
Array
(
[id] => 19075311
[patent_doc_number] => 11944654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Bacteriotherapy for clostridium difficile colitis
[patent_app_type] => utility
[patent_app_number] => 17/886274
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 12416
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17886274
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/886274 | Bacteriotherapy for clostridium difficile colitis | Aug 10, 2022 | Issued |
Array
(
[id] => 19513409
[patent_doc_number] => 20240345095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => AN ASSAY FOR DETERMINING GASTROINTESTINAL PERMEABILITY BY DETERMINING A RATIO OF THE CONCENTRATION OF LACTULOSE TO THE CONCENTRATION OF GALACTOSE IN THE BLOOD SAMPLE
[patent_app_type] => utility
[patent_app_number] => 18/294793
[patent_app_country] => US
[patent_app_date] => 2022-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18294793
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/294793 | AN ASSAY FOR DETERMINING GASTROINTESTINAL PERMEABILITY BY DETERMINING A RATIO OF THE CONCENTRATION OF LACTULOSE TO THE CONCENTRATION OF GALACTOSE IN THE BLOOD SAMPLE | Jul 20, 2022 | Pending |
Array
(
[id] => 19479767
[patent_doc_number] => 20240327809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => Enzymes and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/578768
[patent_app_country] => US
[patent_app_date] => 2022-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18578768
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/578768 | Enzymes and Uses Thereof | Jul 14, 2022 | Pending |
Array
(
[id] => 18228267
[patent_doc_number] => 20230067261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHODS FOR TREATING INFLAMMATORY CONDITIONS OF THE LUNGS
[patent_app_type] => utility
[patent_app_number] => 17/861912
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861912
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/861912 | METHODS FOR TREATING INFLAMMATORY CONDITIONS OF THE LUNGS | Jul 10, 2022 | Abandoned |
Array
(
[id] => 18124495
[patent_doc_number] => 20230010107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => PROCESS FOR PRODUCING PLATELET-RICH FIBRIN MATRIX FROM PLATELET-RICH PLASMA
[patent_app_type] => utility
[patent_app_number] => 17/861764
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861764
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/861764 | PROCESS FOR PRODUCING PLATELET-RICH FIBRIN MATRIX FROM PLATELET-RICH PLASMA | Jul 10, 2022 | Pending |
Array
(
[id] => 18418583
[patent_doc_number] => 20230173041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/856121
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856121
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/856121 | NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS | Jun 30, 2022 | Abandoned |
Array
(
[id] => 20599021
[patent_doc_number] => 20260077024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-03-19
[patent_title] => AGENT FOR IMPROVING INTESTINAL FLORA
[patent_app_type] => utility
[patent_app_number] => 18/579230
[patent_app_country] => US
[patent_app_date] => 2022-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18579230
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/579230 | AGENT FOR IMPROVING INTESTINAL FLORA | Jun 19, 2022 | Pending |
Array
(
[id] => 18162784
[patent_doc_number] => 20230029377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => METHODS AND COMPOSITIONS TO PROMOTING RETINAL REGENERATION USING PROX1 MIGRATION INHIBITOR AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 17/842610
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842610
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842610 | Methods and compositions to promoting retinal regeneration using prox1 migration inhibitor as active ingredient | Jun 15, 2022 | Issued |
Array
(
[id] => 19403978
[patent_doc_number] => 20240287489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => CHITINOLYTIC ENZYME-BASED PLANT PROTECTION AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/570470
[patent_app_country] => US
[patent_app_date] => 2022-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20639
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570470
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570470 | CHITINOLYTIC ENZYME-BASED PLANT PROTECTION AGENTS | Jun 14, 2022 | Pending |
Array
(
[id] => 20276808
[patent_doc_number] => 20250302050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-02
[patent_title] => PEST CONTROL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/863109
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18863109
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/863109 | PEST CONTROL COMPOSITIONS | May 30, 2022 | Pending |
Array
(
[id] => 19361174
[patent_doc_number] => 20240263208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => CYTOCHROME P450 ENZYME
[patent_app_type] => utility
[patent_app_number] => 18/563988
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563988
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563988 | CYTOCHROME P450 ENZYME | May 25, 2022 | Pending |
Array
(
[id] => 19319596
[patent_doc_number] => 20240241139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => DIAGNOSIS OF AUTISM SPECTRUM DISORDER BY MULTIOMICS PLATFORM
[patent_app_type] => utility
[patent_app_number] => 18/563900
[patent_app_country] => US
[patent_app_date] => 2022-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563900
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563900 | DIAGNOSIS OF AUTISM SPECTRUM DISORDER BY MULTIOMICS PLATFORM | May 24, 2022 | Pending |
Array
(
[id] => 18019459
[patent_doc_number] => 20220370958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => ANTIBODY CONJUGATED NANOPARTICLE ASSAY AND TREATMENT FOR SARS-CoV-2
[patent_app_type] => utility
[patent_app_number] => 17/747322
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747322
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/747322 | ANTIBODY CONJUGATED NANOPARTICLE ASSAY AND TREATMENT FOR SARS-CoV-2 | May 17, 2022 | Abandoned |
Array
(
[id] => 19318328
[patent_doc_number] => 20240239871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => HYPERSIALYLATING CELLS
[patent_app_type] => utility
[patent_app_number] => 18/557772
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557772
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557772 | HYPERSIALYLATING CELLS | Apr 26, 2022 | Pending |
Array
(
[id] => 17930111
[patent_doc_number] => 20220325236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => BIOCOMPATIBLE CONDITIONED CELL MEDIUM COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/727323
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727323
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/727323 | Biocompatible conditioned cell medium compositions and uses thereof | Apr 21, 2022 | Issued |
Array
(
[id] => 20295237
[patent_doc_number] => 20250320480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-16
[patent_title] => Immunoglobulin Cleaving Enzyme
[patent_app_type] => utility
[patent_app_number] => 18/287565
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287565
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287565 | Immunoglobulin Cleaving Enzyme | Apr 21, 2022 | Pending |
Array
(
[id] => 17760138
[patent_doc_number] => 20220233750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => CROSSLINKED SOFT TISSUE GRAFT AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/721604
[patent_app_country] => US
[patent_app_date] => 2022-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17721604
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/721604 | Crosslinked soft tissue graft and methods of use thereof | Apr 14, 2022 | Issued |